ACEi and ARBs

Remind your patients to NOT stop taking their blood pressure medications

• At the present time, there is NO confirmed scientific link between angiotensin converting enzyme inhibitors (ACE-i) or Angiotensin Receptor Blockers (ARBs) and the risk of COVID-19 infection or its complications.

• Blood pressure control is an essential part when managing diabetes, and ACEi and ARBs are often recommended for people living with diabetes to prevent and treat cardiac and renal complications 

   

For more information, please refer to:

• Diabetes Canada FAQ

• Canadian Cardiovascular Society UPDATED – COVID-19 and concerns regarding use of cardiovascular medications, including ACEi/ARB/ARNi, low-dose ASA and non-steroidal anti-inflammatory drugs (NSAIDS)